{"transactions":[{"id":721194,"issuer":{"id":5371,"kind":"organization","name":"ASP Isotopes Inc.","symbol":"ASPI"},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-02T01:45:38.000Z","date":"2026-06-30","kind":"sale","planned":false,"acquired":false,"shares":50000,"price":6.12,"value":306000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.10 to $6.25, inclusive. The reporting person undertakes to provide the Company, any stockholder of the\nCompany, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":672247,"source":{"system":"sec-edgar","filing":"0001477932-26-004157","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1642715/000147793226004157/form4.xml","form_type":"4"}},{"id":721193,"issuer":{"id":5371,"kind":"organization","name":"ASP Isotopes Inc.","symbol":"ASPI"},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-02T01:45:38.000Z","date":"2026-06-29","kind":"sale","planned":false,"acquired":false,"shares":50000,"price":6.25,"value":312500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.21 to $6.31, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the \"Company\"),\nany stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":722247,"source":{"system":"sec-edgar","filing":"0001477932-26-004157","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642715/000147793226004157/form4.xml","form_type":"4"}},{"id":960962,"issuer":{"id":5371,"kind":"organization","name":"ASP Isotopes Inc.","symbol":"ASPI"},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-23T02:03:20.000Z","date":"2025-12-18","kind":"grant","planned":false,"acquired":true,"shares":36548,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Annual award of shares of restricted stock in connection with the reporting person's service as an independent director of ASP Isotopes Inc."}],"balance_after":772247,"source":{"system":"sec-edgar","filing":"0001477932-25-009171","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642715/000147793225009171/form4.xml","form_type":"4"}},{"id":998847,"issuer":{"id":5371,"kind":"organization","name":"ASP Isotopes Inc.","symbol":"ASPI"},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-15T02:34:57.000Z","date":"2025-11-12","kind":"grant","planned":false,"acquired":true,"shares":25469,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Award of shares of restricted stock in connection with the reporting person's service as an independent director of ASP Isotopes Inc. on the QLE Structuring and Strategic Transactions Committee."}],"balance_after":735699,"source":{"system":"sec-edgar","filing":"0001477932-25-008354","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642715/000147793225008354/form4.xml","form_type":"4"}},{"id":1024531,"issuer":{"id":5371,"kind":"organization","name":"ASP Isotopes Inc.","symbol":"ASPI"},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-10-04T00:25:54.000Z","date":"2025-09-14","kind":"exercise","planned":false,"acquired":false,"shares":96000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options vested in a single installment 12 months after the grant date. The option was granted on April 4, 2022."}],"balance_after":0,"derivative":{"exercise_price":2,"exercise_date":"2023-04-04","expiration_date":"2032-04-04","underlying":"Common Stock","underlying_shares":96000},"source":{"system":"sec-edgar","filing":"0001477932-25-007349","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1642715/000147793225007349/form4.xml","form_type":"4"}},{"id":1024530,"issuer":{"id":5371,"kind":"organization","name":"ASP Isotopes Inc.","symbol":"ASPI"},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-04T00:25:54.000Z","date":"2025-09-15","kind":"sale","planned":false,"acquired":false,"shares":74108,"price":8.7551,"value":648822.9508,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale of shares reported in this Form 4 includes an amount for the purpose of satisfying the reporting person's income tax liabilities resulting from the vesting of a previously granted restricted stock award and the exercise of a stock option issued pursuant to an issuer equity incentive plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.37 to $9.40, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the \"Company\"), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 3."}],"balance_after":710230,"source":{"system":"sec-edgar","filing":"0001477932-25-007349","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1642715/000147793225007349/form4.xml","form_type":"4"}},{"id":1024529,"issuer":{"id":5371,"kind":"organization","name":"ASP Isotopes Inc.","symbol":"ASPI"},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-04T00:25:54.000Z","date":"2025-09-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":21892,"price":8.77,"value":191992.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company in connection with net share settlement to satisfy the exercise price associated with the reporting person's exercise of a stock option."}],"balance_after":784338,"source":{"system":"sec-edgar","filing":"0001477932-25-007349","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1642715/000147793225007349/form4.xml","form_type":"4"}},{"id":1024528,"issuer":{"id":5371,"kind":"organization","name":"ASP Isotopes Inc.","symbol":"ASPI"},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-04T00:25:54.000Z","date":"2025-09-14","kind":"exercise","planned":false,"acquired":true,"shares":96000,"price":2,"value":192000.0,"ownership":{"direct":true},"balance_after":806230,"source":{"system":"sec-edgar","filing":"0001477932-25-007349","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642715/000147793225007349/form4.xml","form_type":"4"}},{"id":1355729,"issuer":{"id":5371,"kind":"organization","name":"ASP Isotopes Inc.","symbol":"ASPI"},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-22T00:34:24.000Z","date":"2024-11-20","kind":"grant","planned":false,"acquired":true,"shares":42522,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Annual award of common stock for service as an independent director of ASP Isotopes Inc."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Annual award of common stock for service as an independent director of ASP Isotopes Inc."}],"balance_after":710230,"source":{"system":"sec-edgar","filing":"0001477932-24-007551","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642715/000147793224007551/form4.xml","form_type":"4"}},{"id":1433609,"issuer":{"id":5371,"kind":"organization","name":"ASP Isotopes Inc.","symbol":"ASPI"},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-15T00:02:28.000Z","date":"2024-08-13","kind":"grant","planned":false,"acquired":true,"shares":95238,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This award of common stock was issued in lieu of quarterly cash fees payable to the reporting person for service as an independent director of ASP Isotopes Inc."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Annual award of common stock for service as an independent director of ASP Isotopes Inc."}],"balance_after":667708,"source":{"system":"sec-edgar","filing":"0001477932-24-004881","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1642715/000147793224004881/form4.xml","form_type":"4"}},{"id":1433608,"issuer":{"id":5371,"kind":"organization","name":"ASP Isotopes Inc.","symbol":"ASPI"},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-15T00:02:28.000Z","date":"2024-08-13","kind":"grant","planned":false,"acquired":true,"shares":77626,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This award of common stock was issued in lieu of quarterly cash fees payable to the reporting person for service as an independent director of ASP Isotopes Inc."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This award of common stock was issued in lieu of quarterly cash fees payable to the reporting person for service as an independent director of ASP Isotopes Inc."}],"balance_after":572470,"source":{"system":"sec-edgar","filing":"0001477932-24-004881","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642715/000147793224004881/form4.xml","form_type":"4"}},{"id":1445276,"issuer":{"id":88618,"kind":"organization","name":"ARYA Sciences Acquisition Corp IV","symbol":"ARYD"},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true}}],"security":"Class B ordinary shares","published_at":"2024-08-01T01:43:24.000Z","date":"2024-07-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the Business Combination Agreement, dated February 13, 2024, by and among the Issuer, Adagio Medical Holdings, Inc. (f/k/a Aja HoldCo, Inc.) (\"HoldCo\"), Aja Merger Sub 1 (\"Merger Sub 1\"), Aja Merger Sub 2, Inc. (\"Merger Sub 2\") and Adagio Medical, Inc. (\"Adagio\") (the transactions contemplated thereby, the \"Business Combination\"), Merger Sub merged with and into the Issuer and Merger Sub 2 merged with and into Adagio, with each of the Issuer and Adagio becoming a wholly owned subsidiary of HoldCo, and the Reporting Person's ordinary shares of the Issuer were automatically converted into shares of common stock of HoldCo, par value $0.0001 per share, on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the Business Combination Agreement, dated February 13, 2024, by and among the Issuer, Adagio Medical Holdings, Inc. (f/k/a Aja HoldCo, Inc.) (\"HoldCo\"), Aja Merger Sub 1 (\"Merger Sub 1\"), Aja Merger Sub 2, Inc. (\"Merger Sub 2\") and Adagio Medical, Inc. (\"Adagio\") (the transactions contemplated thereby, the \"Business Combination\"), Merger Sub merged with and into the Issuer and Merger Sub 2 merged with and into Adagio, with each of the Issuer and Adagio becoming a wholly owned subsidiary of HoldCo, and the Reporting Person's ordinary shares of the Issuer were automatically converted into shares of common stock of HoldCo, par value $0.0001 per share, on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the Business Combination Agreement, dated February 13, 2024, by and among the Issuer, Adagio Medical Holdings, Inc. (f/k/a Aja HoldCo, Inc.) (\"HoldCo\"), Aja Merger Sub 1 (\"Merger Sub 1\"), Aja Merger Sub 2, Inc. (\"Merger Sub 2\") and Adagio Medical, Inc. (\"Adagio\") (the transactions contemplated thereby, the \"Business Combination\"), Merger Sub merged with and into the Issuer and Merger Sub 2 merged with and into Adagio, with each of the Issuer and Adagio becoming a wholly owned subsidiary of HoldCo, and the Reporting Person's ordinary shares of the Issuer were automatically converted into shares of common stock of HoldCo, par value $0.0001 per share, on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the Business Combination Agreement, dated February 13, 2024, by and among the Issuer, Adagio Medical Holdings, Inc. (f/k/a Aja HoldCo, Inc.) (\"HoldCo\"), Aja Merger Sub 1 (\"Merger Sub 1\"), Aja Merger Sub 2, Inc. (\"Merger Sub 2\") and Adagio Medical, Inc. (\"Adagio\") (the transactions contemplated thereby, the \"Business Combination\"), Merger Sub merged with and into the Issuer and Merger Sub 2 merged with and into Adagio, with each of the Issuer and Adagio becoming a wholly owned subsidiary of HoldCo, and the Reporting Person's ordinary shares of the Issuer were automatically converted into shares of common stock of HoldCo, par value $0.0001 per share, on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the Business Combination Agreement, dated February 13, 2024, by and among the Issuer, Adagio Medical Holdings, Inc. (f/k/a Aja HoldCo, Inc.) (\"HoldCo\"), Aja Merger Sub 1 (\"Merger Sub 1\"), Aja Merger Sub 2, Inc. (\"Merger Sub 2\") and Adagio Medical, Inc. (\"Adagio\") (the transactions contemplated thereby, the \"Business Combination\"), Merger Sub merged with and into the Issuer and Merger Sub 2 merged with and into Adagio, with each of the Issuer and Adagio becoming a wholly owned subsidiary of HoldCo, and the Reporting Person's ordinary shares of the Issuer were automatically converted into shares of common stock of HoldCo, par value $0.0001 per share, on a one-for-one basis."}],"balance_after":0,"derivative":{"underlying":"Class A ordinary shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001140361-24-035170","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642715/000114036124035170/form4.xml","form_type":"4"}},{"id":1753808,"issuer":{"id":5371,"kind":"organization","name":"ASP Isotopes Inc.","symbol":"ASPI"},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-31T01:51:14.000Z","date":"2023-10-26","kind":"purchase","planned":false,"acquired":true,"shares":94844,"price":0.96,"value":91050.24,"ownership":{"direct":true},"footnotes":[{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F1","text":"Shares of the Issuer's Common Stock were purchased in the Issuer's private placement of Common pursuant to a Securities Purchase Agreement, dated October 9, 2023, by and among the Issuer and the other purchasers named therein. The shares of Common Stock acquired were purchased at a price per share of $0.96 per share of Common Stock (the consolidated closing bid price per share immediately preceding the signing of the binding agreement to issue the securities)."}],"balance_after":494844,"source":{"system":"sec-edgar","filing":"0001477932-23-007983","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642715/000147793223007983/form4.xml","form_type":"4"}},{"id":2114515,"issuer":{"id":5371,"kind":"organization","name":"ASP Isotopes Inc.","symbol":"ASPI"},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-16T17:50:54.000Z","date":"2022-11-15","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F1","text":"This special one-time equity award of 200,000 restricted shares was contingent upon the completion of our IPO. Mr. Wider will receive 100,000 restricted shares of our common stock on November 15, 2023 and 100,000 restricted shares of our common stock on November 15, 2024."}],"balance_after":400000,"source":{"system":"sec-edgar","filing":"0001213900-22-073100","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642715/000121390022073100/ownership.xml","form_type":"4"}},{"id":2150196,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-28T20:36:40.000Z","date":"2022-09-26","kind":"grant","acquired":true,"shares":13400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All of the restricted stock will vest on September 26, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On July 1, 2022, the issuer effectuated a 1-for-25 reverse stock split."}],"balance_after":16907,"source":{"system":"sec-edgar","filing":"0001493152-22-027047","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315222027047/ownership.xml","form_type":"4"}},{"id":2545914,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-09T00:33:23.000Z","date":"2021-10-07","kind":"sale","acquired":false,"shares":25000,"price":0.966,"value":24150.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.9624 to $0.9661, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001493152-21-025086","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221025086/ownership.xml","form_type":"4"}},{"id":2694358,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-28T01:49:09.000Z","date":"2021-05-25","kind":"grant","acquired":true,"shares":49084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the stock options will vest on November 25, 2021."}],"balance_after":49084,"derivative":{"exercise_price":1.49,"expiration_date":"2031-05-25","underlying":"Common Stock","underlying_shares":49084},"source":{"system":"sec-edgar","filing":"0001493152-21-013125","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221013125/ownership.xml","form_type":"4"}},{"id":2694357,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-28T01:49:09.000Z","date":"2021-05-25","kind":"grant","acquired":true,"shares":38590,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All of the restricted stock will vest on November 25, 2021."}],"balance_after":63590,"source":{"system":"sec-edgar","filing":"0001493152-21-013125","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221013125/ownership.xml","form_type":"4"}},{"id":2841557,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-23T21:05:31.000Z","date":"2021-02-19","kind":"sale","acquired":false,"shares":251625,"price":2.3887,"value":601056.6375,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.371 to $2.402, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001493152-21-004592","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221004592/ownership.xml","form_type":"4"}},{"id":2847875,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-19T21:05:25.000Z","date":"2021-02-18","kind":"exercise","acquired":false,"shares":1345,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.28,"exercise_date":"2020-11-20","expiration_date":"2030-05-20","underlying":"Common Stock","underlying_shares":1345},"source":{"system":"sec-edgar","filing":"0001493152-21-004407","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221004407/ownership.xml","form_type":"4"}},{"id":2847874,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-19T21:05:25.000Z","date":"2021-02-17","kind":"exercise","acquired":false,"shares":20173,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1345,"derivative":{"exercise_price":1.28,"exercise_date":"2020-11-20","expiration_date":"2030-05-20","underlying":"Common Stock","underlying_shares":20173},"source":{"system":"sec-edgar","filing":"0001493152-21-004407","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221004407/ownership.xml","form_type":"4"}},{"id":2847873,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-19T21:05:25.000Z","date":"2021-02-17","kind":"exercise","acquired":false,"shares":19827,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.28,"exercise_date":"2019-11-21","expiration_date":"2029-05-21","underlying":"Common Stock","underlying_shares":19827},"source":{"system":"sec-edgar","filing":"0001493152-21-004407","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221004407/ownership.xml","form_type":"4"}},{"id":2847872,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-19T21:05:25.000Z","date":"2021-02-17","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.28,"exercise_date":"2018-09-29","expiration_date":"2028-03-29","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-21-004407","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221004407/ownership.xml","form_type":"4"}},{"id":2847871,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-19T21:05:25.000Z","date":"2021-02-17","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.28,"exercise_date":"2018-05-14","expiration_date":"2027-12-14","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001493152-21-004407","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221004407/ownership.xml","form_type":"4"}},{"id":2847870,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-19T21:05:25.000Z","date":"2021-02-17","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.28,"exercise_date":"2017-05-13","expiration_date":"2026-12-13","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-21-004407","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221004407/ownership.xml","form_type":"4"}},{"id":2847869,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-19T21:05:25.000Z","date":"2021-02-17","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.28,"exercise_date":"2016-08-11","expiration_date":"2026-02-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-21-004407","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221004407/ownership.xml","form_type":"4"}},{"id":2847868,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-19T21:05:25.000Z","date":"2021-02-17","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.28,"exercise_date":"2015-11-11","expiration_date":"2025-05-11","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-21-004407","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221004407/ownership.xml","form_type":"4"}},{"id":2847867,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T21:05:25.000Z","date":"2021-02-18","kind":"sale","acquired":false,"shares":1345,"price":2.4333,"value":3272.7885,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.43 to $2.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote."}],"balance_after":276625,"source":{"system":"sec-edgar","filing":"0001493152-21-004407","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221004407/ownership.xml","form_type":"4"}},{"id":2847866,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T21:05:25.000Z","date":"2021-02-18","kind":"exercise","acquired":true,"shares":1345,"price":1.28,"value":1721.6,"ownership":{"direct":true},"balance_after":277970,"source":{"system":"sec-edgar","filing":"0001493152-21-004407","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221004407/ownership.xml","form_type":"4"}},{"id":2847865,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T21:05:25.000Z","date":"2021-02-17","kind":"sale","acquired":false,"shares":320000,"price":2.3431,"value":749792.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.30 to $2.475, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote."}],"balance_after":276625,"source":{"system":"sec-edgar","filing":"0001493152-21-004407","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221004407/ownership.xml","form_type":"4"}},{"id":2847864,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T21:05:25.000Z","date":"2021-02-17","kind":"exercise","acquired":true,"shares":20173,"price":1.28,"value":25821.44,"ownership":{"direct":true},"balance_after":596625,"source":{"system":"sec-edgar","filing":"0001493152-21-004407","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221004407/ownership.xml","form_type":"4"}},{"id":2847863,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T21:05:25.000Z","date":"2021-02-17","kind":"exercise","acquired":true,"shares":19827,"price":1.28,"value":25378.56,"ownership":{"direct":true},"balance_after":576452,"source":{"system":"sec-edgar","filing":"0001493152-21-004407","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221004407/ownership.xml","form_type":"4"}},{"id":2847862,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T21:05:25.000Z","date":"2021-02-17","kind":"exercise","acquired":true,"shares":50000,"price":1.28,"value":64000.0,"ownership":{"direct":true},"balance_after":566625,"source":{"system":"sec-edgar","filing":"0001493152-21-004407","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221004407/ownership.xml","form_type":"4"}},{"id":2847861,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T21:05:25.000Z","date":"2021-02-17","kind":"exercise","acquired":true,"shares":30000,"price":1.28,"value":38400.0,"ownership":{"direct":true},"balance_after":506625,"source":{"system":"sec-edgar","filing":"0001493152-21-004407","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221004407/ownership.xml","form_type":"4"}},{"id":2847860,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T21:05:25.000Z","date":"2021-02-17","kind":"exercise","acquired":true,"shares":50000,"price":1.28,"value":64000.0,"ownership":{"direct":true},"balance_after":476625,"source":{"system":"sec-edgar","filing":"0001493152-21-004407","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221004407/ownership.xml","form_type":"4"}},{"id":2847859,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T21:05:25.000Z","date":"2021-02-17","kind":"exercise","acquired":true,"shares":50000,"price":1.28,"value":64000.0,"ownership":{"direct":true},"balance_after":426625,"source":{"system":"sec-edgar","filing":"0001493152-21-004407","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221004407/ownership.xml","form_type":"4"}},{"id":2847858,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T21:05:25.000Z","date":"2021-02-17","kind":"exercise","acquired":true,"shares":100000,"price":1.28,"value":128000.0,"ownership":{"direct":true},"balance_after":376625,"source":{"system":"sec-edgar","filing":"0001493152-21-004407","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221004407/ownership.xml","form_type":"4"}},{"id":2923867,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-06T00:09:33.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":33876,"price":1.5369,"value":52064.0244,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were to cover tax obligations associated with vested restricted stock awards and were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 19, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.50 to $1.575, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote."}],"balance_after":276625,"source":{"system":"sec-edgar","filing":"0001493152-21-000249","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221000249/ownership.xml","form_type":"4"}},{"id":2923866,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-06T00:09:33.000Z","date":"2020-12-31","kind":"disposition_to_issuer","acquired":false,"shares":609755,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents unvested shares of restricted common stock granted to the reporting person on October 8, 2020 in connection with the formation of a special committee of the Issuer's board of directors as reported on Form 8-K on October 6, 2020. These shares were scheduled to vest in monthly installments only while the special committee was operational and the reporting person was providing service to the special committee; the special committee was dissolved on December 31, 2020. The reporting person continues to serve on the Issuer's board of directors."}],"balance_after":310501,"source":{"system":"sec-edgar","filing":"0001493152-21-000249","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221000249/ownership.xml","form_type":"4"}},{"id":2962001,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-02T21:26:38.000Z","date":"2020-12-02","kind":"sale","acquired":false,"shares":33876,"price":1.4921,"value":50546.3796,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to cover tax obligations associated with vested restricted stock awards and were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 19, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.46 to $1.565, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote."}],"balance_after":920256,"source":{"system":"sec-edgar","filing":"0001493152-20-022828","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022828/ownership.xml","form_type":"4"}},{"id":2969060,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-24T23:46:59.000Z","date":"2020-11-23","kind":"sale","acquired":false,"shares":17969,"price":1.3346,"value":23981.4274,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 19, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.32 to $1.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote."}],"balance_after":954132,"source":{"system":"sec-edgar","filing":"0001493152-20-022466","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022466/ownership.xml","form_type":"4"}},{"id":2972234,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:12.000Z","date":"2020-11-20","kind":"disposition_to_issuer","acquired":false,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, May 21, 2019, March 29, 2018, December 14, 2017, December 13, 2016, February 11, 2016 and May 11, 2015 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The options vested 100% on November 11, 2015."}],"balance_after":0,"derivative":{"exercise_price":7.34,"expiration_date":"2025-05-11","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-20-022153","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022153/ownership.xml","form_type":"4"}},{"id":2972233,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:12.000Z","date":"2020-11-20","kind":"grant","acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, May 21, 2019, March 29, 2018, December 14, 2017, December 13, 2016, February 11, 2016 and May 11, 2015 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The options vested 100% on November 11, 2015."}],"balance_after":100000,"derivative":{"exercise_price":1.28,"expiration_date":"2025-05-11","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-20-022153","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022153/ownership.xml","form_type":"4"}},{"id":2972232,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:12.000Z","date":"2020-11-20","kind":"disposition_to_issuer","acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, May 21, 2019, March 29, 2018, December 14, 2017, December 13, 2016, February 11, 2016 and May 11, 2015 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The options vested 100% on August 11, 2016."}],"balance_after":0,"derivative":{"exercise_price":2.31,"expiration_date":"2026-02-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-20-022153","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022153/ownership.xml","form_type":"4"}},{"id":2972231,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:12.000Z","date":"2020-11-20","kind":"grant","acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, May 21, 2019, March 29, 2018, December 14, 2017, December 13, 2016, February 11, 2016 and May 11, 2015 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The options vested 100% on August 11, 2016."}],"balance_after":50000,"derivative":{"exercise_price":1.28,"expiration_date":"2026-02-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-20-022153","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022153/ownership.xml","form_type":"4"}},{"id":2972230,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:12.000Z","date":"2020-11-20","kind":"disposition_to_issuer","acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, May 21, 2019, March 29, 2018, December 14, 2017, December 13, 2016, February 11, 2016 and May 11, 2015 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options vested 100% on June 13, 2017."}],"balance_after":0,"derivative":{"exercise_price":4.45,"expiration_date":"2026-12-13","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-20-022153","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022153/ownership.xml","form_type":"4"}},{"id":2972229,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:12.000Z","date":"2020-11-20","kind":"grant","acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, May 21, 2019, March 29, 2018, December 14, 2017, December 13, 2016, February 11, 2016 and May 11, 2015 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options vested 100% on June 13, 2017."}],"balance_after":50000,"derivative":{"exercise_price":1.28,"expiration_date":"2026-12-13","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-20-022153","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022153/ownership.xml","form_type":"4"}},{"id":2972228,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:12.000Z","date":"2020-11-20","kind":"disposition_to_issuer","acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, May 21, 2019, March 29, 2018, December 14, 2017, December 13, 2016, February 11, 2016 and May 11, 2015 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vested 100% on June 14, 2018."}],"balance_after":0,"derivative":{"exercise_price":16,"expiration_date":"2027-12-14","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001493152-20-022153","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022153/ownership.xml","form_type":"4"}},{"id":2972227,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:12.000Z","date":"2020-11-20","kind":"grant","acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, May 21, 2019, March 29, 2018, December 14, 2017, December 13, 2016, February 11, 2016 and May 11, 2015 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vested 100% on June 14, 2018."}],"balance_after":30000,"derivative":{"exercise_price":1.28,"expiration_date":"2027-12-14","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001493152-20-022153","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022153/ownership.xml","form_type":"4"}},{"id":2972226,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:12.000Z","date":"2020-11-20","kind":"disposition_to_issuer","acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, May 21, 2019, March 29, 2018, December 14, 2017, December 13, 2016, February 11, 2016 and May 11, 2015 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vested 100% on September 29, 2018."}],"balance_after":0,"derivative":{"exercise_price":13.65,"expiration_date":"2028-03-29","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-20-022153","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022153/ownership.xml","form_type":"4"}},{"id":2972225,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:12.000Z","date":"2020-11-20","kind":"grant","acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, May 21, 2019, March 29, 2018, December 14, 2017, December 13, 2016, February 11, 2016 and May 11, 2015 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vested 100% on September 29, 2018."}],"balance_after":50000,"derivative":{"exercise_price":1.28,"expiration_date":"2028-03-29","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-20-022153","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022153/ownership.xml","form_type":"4"}},{"id":2972224,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:12.000Z","date":"2020-11-20","kind":"disposition_to_issuer","acquired":false,"shares":19827,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, May 21, 2019, March 29, 2018, December 14, 2017, December 13, 2016, February 11, 2016 and May 11, 2015 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vested 100% on November 21, 2019."}],"balance_after":0,"derivative":{"exercise_price":7.42,"expiration_date":"2029-05-21","underlying":"Common Stock","underlying_shares":19827},"source":{"system":"sec-edgar","filing":"0001493152-20-022153","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022153/ownership.xml","form_type":"4"}},{"id":2972223,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:12.000Z","date":"2020-11-20","kind":"grant","acquired":true,"shares":19827,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, May 21, 2019, March 29, 2018, December 14, 2017, December 13, 2016, February 11, 2016 and May 11, 2015 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vested 100% on November 21, 2019."}],"balance_after":19827,"derivative":{"exercise_price":1.28,"expiration_date":"2029-05-21","underlying":"Common Stock","underlying_shares":19827},"source":{"system":"sec-edgar","filing":"0001493152-20-022153","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022153/ownership.xml","form_type":"4"}},{"id":2972222,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:12.000Z","date":"2020-11-20","kind":"disposition_to_issuer","acquired":false,"shares":21518,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, May 21, 2019, March 29, 2018, December 14, 2017, December 13, 2016, February 11, 2016 and May 11, 2015 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on November 20, 2020."}],"balance_after":0,"derivative":{"exercise_price":3.2,"expiration_date":"2030-05-20","underlying":"Common Stock","underlying_shares":21518},"source":{"system":"sec-edgar","filing":"0001493152-20-022153","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022153/ownership.xml","form_type":"4"}},{"id":2972221,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:12.000Z","date":"2020-11-20","kind":"grant","acquired":true,"shares":21518,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on May 20, 2020, May 21, 2019, March 29, 2018, December 14, 2017, December 13, 2016, February 11, 2016 and May 11, 2015 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on November 20, 2020."}],"balance_after":21518,"derivative":{"exercise_price":1.28,"expiration_date":"2030-05-20","underlying":"Common Stock","underlying_shares":21518},"source":{"system":"sec-edgar","filing":"0001493152-20-022153","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022153/ownership.xml","form_type":"4"}},{"id":2990556,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-06T21:55:05.000Z","date":"2020-11-02","kind":"sale","acquired":false,"shares":33876,"price":1.0363,"value":35105.6988,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to cover tax obligations associated with vested restricted stock awards and were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 19, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.03 to $1.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote."}],"balance_after":972101,"source":{"system":"sec-edgar","filing":"0001493152-20-020709","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220020709/ownership.xml","form_type":"4"}},{"id":3008893,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-13T22:28:46.000Z","date":"2020-10-08","kind":"grant","acquired":true,"shares":813008,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest in 12 equal monthly installments beginning on October 31, 2020."}],"balance_after":1005977,"source":{"system":"sec-edgar","filing":"0001493152-20-019385","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220019385/ownership.xml","form_type":"4"}},{"id":3088843,"issuer":{"id":147975,"kind":"organization","name":"ARYA SCIENCES ACQUISITION CORP.","symbol":"ARYA"},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Ordinary Shares","published_at":"2020-07-07T01:57:15.000Z","date":"2020-07-01","kind":"disposition_to_issuer","acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the merger of ARYA Sciences Acquisition Corp. (the \"Issuer\") with and into a subsidiary of Immatics N.V. (\"IMTX\"), and a series of related transactions (collectively, the \"Business Combination\"), the Class B Ordinary Shares, par value $0.0001 per share, of the Issuer held by the Reporting Person were exchanged for Ordinary Shares, nominal value EURO0.01 per share, of IMTX. Upon consummation of the Business Combination the Reporting Person is no longer subject to the reporting requirements of Section 16 with respect to the Issuer's securities."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the merger of ARYA Sciences Acquisition Corp. (the \"Issuer\") with and into a subsidiary of Immatics N.V. (\"IMTX\"), and a series of related transactions (collectively, the \"Business Combination\"), the Class B Ordinary Shares, par value $0.0001 per share, of the Issuer held by the Reporting Person were exchanged for Ordinary Shares, nominal value EURO0.01 per share, of IMTX. Upon consummation of the Business Combination the Reporting Person is no longer subject to the reporting requirements of Section 16 with respect to the Issuer's securities."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the merger of ARYA Sciences Acquisition Corp. (the \"Issuer\") with and into a subsidiary of Immatics N.V. (\"IMTX\"), and a series of related transactions (collectively, the \"Business Combination\"), the Class B Ordinary Shares, par value $0.0001 per share, of the Issuer held by the Reporting Person were exchanged for Ordinary Shares, nominal value EURO0.01 per share, of IMTX. Upon consummation of the Business Combination the Reporting Person is no longer subject to the reporting requirements of Section 16 with respect to the Issuer's securities."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the merger of ARYA Sciences Acquisition Corp. (the \"Issuer\") with and into a subsidiary of Immatics N.V. (\"IMTX\"), and a series of related transactions (collectively, the \"Business Combination\"), the Class B Ordinary Shares, par value $0.0001 per share, of the Issuer held by the Reporting Person were exchanged for Ordinary Shares, nominal value EURO0.01 per share, of IMTX. Upon consummation of the Business Combination the Reporting Person is no longer subject to the reporting requirements of Section 16 with respect to the Issuer's securities."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950123-20-006744","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642715/000095012320006744/doc4.xml","form_type":"4"}},{"id":3138316,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-22T22:20:02.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":21518,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the stock options will vest on November 20, 2020."}],"balance_after":21518,"derivative":{"exercise_price":3.2,"expiration_date":"2030-05-20","underlying":"Common Stock","underlying_shares":21518},"source":{"system":"sec-edgar","filing":"0001493152-20-009768","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220009768/ownership.xml","form_type":"4"}},{"id":3138315,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-22T22:20:02.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":17969,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All of the restricted stock will vest on November 20, 2020."}],"balance_after":192969,"source":{"system":"sec-edgar","filing":"0001493152-20-009768","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220009768/ownership.xml","form_type":"4"}},{"id":3514245,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-23T22:25:37.000Z","date":"2019-05-21","kind":"grant","acquired":true,"shares":19827,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19827,"derivative":{"exercise_price":7.42,"exercise_date":"2019-11-21","expiration_date":"2029-05-21","underlying":"Common stock","underlying_shares":19827},"source":{"system":"sec-edgar","filing":"0001144204-19-028027","document":"tv522353_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000114420419028027/tv522353_4.xml","form_type":"4"}},{"id":4129546,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2017-12-18T22:04:55.000Z","date":"2017-12-14","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% accelerated vesting on change of control."}],"balance_after":30000,"derivative":{"exercise_price":16,"exercise_date":"2018-06-14","expiration_date":"2027-12-14","underlying":"Common stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000318306-17-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000031830617000004/primary_doc.xml","form_type":"4"}},{"id":4521339,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2016-12-16T01:18:02.000Z","date":"2016-12-13","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% accelerated vesting on change of control."}],"balance_after":50000,"derivative":{"exercise_price":4.45,"exercise_date":"2017-06-13","expiration_date":"2026-12-13","underlying":"Common stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000318306-16-000054","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000031830616000054/primary_doc.xml","form_type":"4"}},{"id":4563129,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2016-11-09T22:03:15.000Z","date":"2016-11-07","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"all 100,000 restricted common shares will vest on 1/1/18."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0000318306-16-000049","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000031830616000049/primary_doc.xml","form_type":"4"}},{"id":4593780,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33973,"kind":"person","name":"Wider Todd","position":1,"cik":"0001642715","reported_name":"Wider Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2016-09-28T12:34:55.000Z","date":"2016-09-20","kind":"purchase","acquired":true,"shares":5000,"price":5.48,"value":27400.0,"ownership":{"direct":true},"balance_after":75000,"source":{"system":"sec-edgar","filing":"0000318306-16-000047","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000031830616000047/primary_doc.xml","form_type":"4"}}]}